lidoflazine has been researched along with Angina Pectoris, Variant in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrigo, F | 1 |
| Coglitore, S | 1 |
| Virga, T | 1 |
| Giannetto, M | 1 |
| Bramanti, B | 1 |
| Melluso, C | 1 |
| Consolo, F | 1 |
1 other study available for lidoflazine and Angina Pectoris, Variant
| Article | Year |
|---|---|
[Prinzmetal's angina. Considerations on a clinical case].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardi | 1977 |